Category: Press Release - Page 103 - Psychedelic Alpha

Read more about the article atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression

atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression

Post published:September 9, 2021
Post category:Press Release

Read more about the article CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

Post published:September 8, 2021
Post category:Press Release

Read more about the article Danish Synthetic Biology Drug Developer Octarine and British Clinical Research Organisation Clerkenwell Health Partner to Bring Innovative Psychedelics to Patients

Danish Synthetic Biology Drug Developer Octarine and British Clinical Research Organisation Clerkenwell Health Partner to Bring Innovative Psychedelics to Patients

Post published:September 8, 2021
Post category:Press Release

Read more about the article Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1

Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1

Post published:September 8, 2021
Post category:Press Release

Read more about the article PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021

PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021

Post published:September 8, 2021
Post category:Press Release

Read more about the article Danish And British Startups Partner to Bring Innovative Psychedelics to Patients

Danish And British Startups Partner to Bring Innovative Psychedelics to Patients

Post published:September 8, 2021
Post category:Press Release

Read more about the article Red Light Holland Closes Majority Stake in Acadian Exotic Mushrooms, Partnering with Leading Canadian Fresh and Dried Mushroom Producers on East Coast Facility

Red Light Holland Closes Majority Stake in Acadian Exotic Mushrooms, Partnering with Leading Canadian Fresh and Dried Mushroom Producers on East Coast Facility

Post published:September 7, 2021
Post category:Press Release

Read more about the article Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its Drugs to Differentiate Between Their Psychedelic and Non-Psychedelic Effects

Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its Drugs to Differentiate Between Their Psychedelic and Non-Psychedelic Effects

Post published:September 7, 2021
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose

Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose

Post published:September 7, 2021
Post category:Press Release

Read more about the article Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes

Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes

Post published:September 7, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.